Abstract

Neuroinflammation, which is mediated by microglia that release various inflammatory cytokines, is a typical feature of neurodegenerative diseases (NDDs), such as Alzheimer’s disease and Parkinson’s disease. Hence, alleviating neuroinflammation by downregulating pro-inflammatory action, and upregulating anti-inflammatory action of microglia is an efficient therapeutic target for NDDs. In this study, we evaluated whether trichosanthis semen (TS), a dried ripe seed of Trichosanthes kirilowii Maximowicz, reduces lipopolysaccharide (LPS)-induced neuroinflammation by regulating microglial responses in vitro and in vivo. Our results presented that TS reduced the release of pro-inflammatory mediators, such as nitric oxide (NO), inducible NO synthase, tumor necrosis factor-α, interleukin-1β, and interleukin-6 via inhibition of the nuclear factor kappa B (NF-κB) signaling pathway in LPS-treated BV2 microglial cells. Moreover, TS induced anti-inflammatory mediators, such as interleukin-10, found in inflammatory zone 1, and chitinase 3-like 3 by the upregulation of heme oxygenase 1 (HO-1). We further confirmed that TS administration suppressed microglial activation, but enhanced HO-1 expression in LPS-injected mice. These results suggest that TS has anti-neuroinflammatory effects via inhibition of NF-κB signaling through the activation of HO-1, and that TS may be a therapeutical candidate for NDDs treatment.

Highlights

  • Excessive microglia activation induced by inflammatory stimuli, such as lipopolysaccharides (LPS), releases various inflammatory factors, including nitric oxide (NO), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and IL-6 [4,5]

  • We aimed to evaluate whether trichosanthis semen (TS) extract (TSE) can reduce LPS-induced neuroinflammatory responses in BV2 microglial cells or in mouse brains

  • NO released from microglia is an inflammatory mediator, and its overproduction induces neurotoxicity, as well as inflammation [22,23]

Read more

Summary

Introduction

Neuroinflammation, an inflammatory response within the central nervous system (CNS), induces neurodegenerative diseases (NDDs), such as Alzheimer’s disease and Parkinson’s disease [1,2]. Microglia, which play a crucial role like macrophages in the CNS, mediate both innate and acquired immune systems [3]. Excessive microglia activation induced by inflammatory stimuli, such as lipopolysaccharides (LPS), releases various inflammatory factors, including nitric oxide (NO), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and IL-6 [4,5]. Overactivated microglia aggravate neuroinflammation, and induce neuronal death in the CNS [6]. The inhibition of microglial activation would be an efficient therapeutic target in preventing NDDs

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call